Back to Legal & General Group Plc Legal & General Group Plc

ABUSABUS
Showing 8 of 25 quarters

Position history for Legal & General Group PlcLegal & General Group Plc's holdings in ARBUTUS BIOPHARMA CORP

Legal & General Group Plc holds 2.5M shares of ABUS (ARBUTUS BIOPHARMA CORP), worth $11.8M as of 2026-Q2. The position was increased (+2.7% shares). ABUS represents 0.0% of Legal & General Group Plc's portfolio.

Current Value

$11.8M

Current Shares

2.5M

Total Value Change

+$11.3M

Total Shares Change

+2.3M

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Increased
2.5M
+2.7%
$11.8M0.0%$4.80
29
2026-Q1
Increased
2.4M
+1856.2%
$10.8M0.0%$4.69
45
2025-Q4
Decreased
122,761
-1.1%
$590,4800.0%$4.62
0
2025-Q3
Decreased
124,177
-0.3%
$563,7640.0%$4.46
0
2025-Q2
Increased
124,486
+5.1%
$384,6610.0%$3.13
25
2025-Q1
Decreased
118,397
-0.3%
$413,2060.0%$3.50
0
2024-Q4
Decreased
118,693
-18.6%
$388,1250.0%$3.20
0
2024-Q3
Increased
145,797
+856.2%
$561,3190.0%$3.83
39

Other major holders of ABUS: MORGAN STANLEY

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used